药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Ondansetron
Typhoid vaccine
The therapeutic efficacy of Typhoid vaccine can be decreased when used in combination with Ceftibuten.
Ondansetron
BCG vaccine
The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Ceftibuten.
Ondansetron
Hygromycin B
The risk or severity of nephrotoxicity can be increased when Ceftibuten is combined with Hygromycin B.
Ondansetron
Dihydrostreptomycin
The risk or severity of nephrotoxicity can be increased when Ceftibuten is combined with Dihydrostreptomycin.
Ondansetron
Puromycin
The risk or severity of nephrotoxicity can be increased when Ceftibuten is combined with Puromycin.
Ondansetron
Neamine
The risk or severity of nephrotoxicity can be increased when Ceftibuten is combined with Neamine.
Ondansetron
Apramycin
The risk or severity of nephrotoxicity can be increased when Ceftibuten is combined with Apramycin.
Ondansetron
Geneticin
The risk or severity of nephrotoxicity can be increased when Ceftibuten is combined with Geneticin.
Ondansetron
Paromomycin
The risk or severity of nephrotoxicity can be increased when Ceftibuten is combined with Paromomycin.
Ondansetron
Loxoprofen
The risk or severity of nephrotoxicity can be increased when Ceftibuten is combined with Loxoprofen.
Ondansetron
Lithium citrate
The risk or severity of nephrotoxicity can be increased when Ceftibuten is combined with Lithium citrate.
Ondansetron
Lithium cation
The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Ceftibuten.
Ondansetron
Givosiran
The risk or severity of nephrotoxicity can be increased when Ceftibuten is combined with Givosiran.
Ondansetron
Phenazopyridine
The risk or severity of nephrotoxicity can be increased when Ceftibuten is combined with Phenazopyridine.
Ondansetron
Picosulfuric acid
The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with Ceftibuten.
Ondansetron
Zinc cation
Zinc cation can cause a decrease in the absorption of Ceftibuten resulting in a reduced serum concentration and potentially a decrease in efficacy.
Ondansetron
Zinc sulfate, unspecified form
Zinc sulfate, unspecified form can cause a decrease in the absorption of Ceftibuten resulting in a reduced serum concentration and potentially a decrease in efficacy.
Ondansetron
Zinc chloride
Zinc chloride can cause a decrease in the absorption of Ceftibuten resulting in a reduced serum concentration and potentially a decrease in efficacy.
Ondansetron
Zinc glycinate
Zinc glycinate can cause a decrease in the absorption of Ceftibuten resulting in a reduced serum concentration and potentially a decrease in efficacy.
Ondansetron
Zinc acetate
Zinc acetate can cause a decrease in the absorption of Ceftibuten resulting in a reduced serum concentration and potentially a decrease in efficacy.